TriNetX Stock
Global health research network
Sign up today and learn more about TriNetX Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About TriNetX Stock
TriNetX is the global health research network enabling healthcare organizations, biopharmaceutical companies and contract research organizations (CROs) to collaborate, enhance trial design, improve site selection and planning, and bring new therapies to market faster. TriNetX combines real time access to longitudinal clinical data with analytics to answer complex research questions. The TriNetX platform is HIPAA and GDPR compliant.
Funding History
| February 2016 | $2.5M |
|---|---|
| March 2019 | $40.0M |
Management
Chief Commercial Officer
Brian Flaherty
Senior Vice President, Marketing
Jennifer Haas
Chief Medical Officer
Manfred Stapff
Chief Technology Officer
Steve Kundrot
Senior Vice President, Finance & Administration
Chris Fraser
Senior Vice President, Corporate Development
Maulik Mehta
Senior Vice President, Global Data Networks
Steve Lethbridge
Chief Executive Officer
Gadi Lachman
Press
TechCrunch - Apr, 3 2019
On the heels of a $40 million round, TriNetX brings its services for drug trials to EuropeEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
